Source BioScience PLC Holding(s) in Company (1827E)
November 02 2015 - 5:38AM
UK Regulatory
TIDMSBS TIDMNAS
RNS Number : 1827E
Source BioScience PLC
02 November 2015
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES (i)
1. Identity of the issuer or the SOURCE BIOSCIENCE PLC
underlying issuer of existing shares
to which voting rights are attached:
(ii)
-------------------------------------- ----------------------
2 Reason for the notification (please tick the appropriate box
or boxes):
-------------------------------------------------------------------------
An acquisition or disposal of voting rights YES
----------------------------------------------------------------- ------
An acquisition or disposal of qualifying financial instruments
which may result in the acquisition of shares already
issued to which voting rights are attached
----------------------------------------------------------------- ------
An acquisition or disposal of instruments with similar
economic effect to qualifying financial instruments
----------------------------------------------------------------- ------
An event changing the breakdown of voting rights
----------------------------------------------------------------- ------
Other (please
specify):
----------------- ---------------------------------------------- ------
3. Full name of person(s) subject
to the notification obligation: Harwood Capital LLP (as investment
(iii) adviser/manager) and North
Atlantic Smaller Companies
Investment Trust plc
------------------------------------ -------------------------------------
4. Full name of shareholder(s)
(if different from 3.): (iv) 1. NORTH ATLANTIC SMALLER
COMPANIES INVESTMENT TRUST
PLC
2. ORYX INTERNATIONAL GROWTH
FUND LIMITED
------------------------------------ -------------------------------------
5. Date of the transaction and date 29 OCTOBER 2015
on which the threshold is crossed
or reached: (v)
------------------------------------ -------------------------------------
6. Date on which issuer notified: 30 OCTOBER 2015
------------------------------------ -------------------------------------
7. Threshold(s) that is/are crossed
or
reached: (vi, vii) Total Holding through 15%
------------------------------------ -------------------------------------
8. Notified details:
------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the triggering
of to the triggering transaction
shares transaction
if possible
using
the ISIN
CODE
-------------- ---------------------------- --------------------------------------------------------------
Number Number Number Number of voting % of voting rights
of of of shares rights (x)
Shares Voting
Rights
-------------- ------------- ------------- ------------- ------------------------ ---------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
-------------- ------------- ------------- ------------- ------------- --------- ---------- ---------
HOLDER 1 1,500,000 1,500,000 2,750,000 2,750,000 0.79%
HOLDER 2 50,000,000 50,000,000 50,000,000 50,000,000 14.32%
-------------- ------------- ------------- ------------- ------------- --------- ---------- ---------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date (xiii) Conversion rights that rights
Period (xiv) may be
acquired if
the
instrument is
exercised/ converted.
------------------ ------------- -------------- ----------------------- ------------
C: Financial Instruments with similar economic effect to Qualifying
Financial Instruments (xv, xvi)
-----------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting
instrument price date Conversion rights instrument rights (xix,
(xvii) period refers to xx)
(xviii)
------------------ --------- ----------- ------------ ------------------- ----------------
Nominal Delta
------------------ --------- ----------- ------------ ------------------- -------- ------
Total (A+B+C)
------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------ ----------------------------
52,750,000 15.11%
------------------------ ----------------------------
9. Chain of controlled undertakings through which the voting rights and/or
the
financial instruments are effectively held, if applicable: (xxi)
---------------------------------------------------------------------------
Proxy Voting:
--------------------------------------
10. Name of the proxy holder:
------------------------------------
11. Number of voting rights proxy
holder will cease to hold:
------------------------------------
12. Date on which proxy holder will
cease to hold voting rights:
------------------------------------
13. Additional information:
------------------------------- --------------
14. Contact name: Jane Muir
------------------------------- --------------
15. Contact telephone number: 020 8819 6486
------------------------------- --------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUGGAWGUPAGUP
(END) Dow Jones Newswires
November 02, 2015 05:38 ET (10:38 GMT)
Medical Solutions (LSE:MLS)
Historical Stock Chart
From Apr 2024 to May 2024
Medical Solutions (LSE:MLS)
Historical Stock Chart
From May 2023 to May 2024
